Patient-Controlled Analgesia After Major Abdominal Surgery in the Elderly Patient by Viorel Gherghina et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
3 
Patient-Controlled Analgesia After Major 
Abdominal Surgery in the Elderly Patient 
Viorel Gherghina, Gheorghe Nicolae, Iulia Cindea, 
Razvan Popescu and Catalin Grasa 
Emergency Clinical County Hospital Constanta, 
Romania 
1. Introduction 
Effective pain management of acute postoperative pain is mainly a humanitarian action that 
influences directly the length of recovery and hospitalization, therefore having important 
medical, economic, and social consequences. 
As the complexity of analgesic therapies increases, priorities of care must be established to 
balance aggressive pain management with measures to prevent or minimize adverse events 
and to ensure high quality and safe care. 
Analgesia remains the primary pharmacologic intervention for managing hospitalized 
surgical patients. Unintended advancing sedation and respiratory depression are two of the 
most serious analgesic-related adverse events. Multiple factors, including analgesic dose, 
route of administration, duration of therapy, patient-specific factors, and desired goals of 
therapy, can influence the occurrence of these adverse events. Furthermore, there is an 
urgent need to educate all members of the health care team about the dangers and potential 
attributes of administration of sedating medications concomitant with analgesia and the 
importance of initiating rational multimodal analgesic plans to help avoid adverse events. 
Elderly patients frequently pose many challenges perioperatively that are not often seen in 
younger patients. Dementia, frailty, impaired ability to care for oneself, and 
malnourishment may be present at baseline and are likely to worsen postoperatively. The 
elderly are at increased risk of acute delirium and cognitive impairment postoperatively, 
which often complicates recovery and discharge placement. 
Patient-controlled analgesia is a modern and effective method of postoperative pain 
management, mostly after major abdominal surgeries. 
Using a special analgesia pump, the patient can self-administer the analgesic as needed, in 
pre-established bolus doses to which an analgesic basal infusion may not be associated. 
Patient-controlled analgesia (PCA) with intravenous morphine and patient-controlled 
epidural analgesia with a local anaesthetic (sufentanyl-bupivacaine) in combination with an 
opioid (PCEA) are two new techniques, theoretically beneficial. However, these techniques 
have been inadequately evaluated in elderly people. 
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A relatively limited number of studies performed a comparative evaluation of the effects of 
various perioperative analgesic techniques on the overall recovery of elderly patients and 
therefore we undertook a prospective, randomized study to compare the effectiveness and 
possible adverse effects on postoperative pain and recovery of two analgesia and anesthesia 
techniques: general anesthesia in combination with epidural analgesia, followed 
postoperatively by PCEA (sufentanyl-bupivacaine), and general anesthesia followed 
postoperatively by PCA with morphine administered intravenously. 
Secondly, we evaluated the mental status of patients after developing respiratory, 
hemodynamic, and gastrointestinal complications. 
2. Background 
One of the most common methods for providing postoperative analgesia is via patient-
controlled analgesia (PCA). Although the typical approach is to administer opioids via a 
programmable infusion pump, other drugs and other modes of administration are available. 
Patient-controlled analgesia (PCA) is commonly assumed to imply on-demand, intermittent, 
intravenous (IV) administration of opioids under patient control (with or without a 
continuous background infusion).  
This technique is based on the use of a sophisticated microprocessor-controlled infusion 
pump that delivers a preprogrammed dose of opioid when the patient pushes a demand 
button. PCA is a conceptual framework for administration of analgesics . The broader 
concept of PCA is not restricted to a single class of analgesics or a single route or mode of 
administration. Nor should PCA imply the mandatory presence of a sophisticated and 
expensive infusion device. Any analgesic given by any route of delivery (i.e., oral, 
subcutaneous, epidural, peripheral nerve catheter, or transdermal) can be considered PCA if 
administered on immediate patient demand in sufficient quantities.  
2.1 Historical perspective 
Gross undertreatment of acute pain has been well chronicled over the last quarter century 
and likely continues today. The traditional approach of IM opioids given pro re nata (prn) 
results in at least 50% of patients experiencing inadequate pain relief after surgery. 
Marks and Sachar’s landmark 1973 publication ignited a philosophical revolution in 
practitioners’ perception of the adequacy of conventional analgesic practices. Not only did 
this study document that a large proportion of hospitalized patients were undertreated, it 
also exposed that physicians and nurses are misinformed and lack sophistication regarding 
the effective use of opioid analgesics. This began the shift in intellectual milieu from the 
quest for the “perfect” analgesic (with an ever-expanding opioid pharmacopoeia) towards 
optimizing the mode of administration and delivery system for the (perfectly adequate) 
analgesic drugs that already existed.  
Roe was the first to demonstrate, in 1963, that small IV doses of opioids provide more 
effective pain relief than conventional IM injections. Subsequently, Sechzer —the true 
pioneer of PCA—evaluated the analgesic response to small IV doses of opioid given on 
patient demand by a nurse in 1968 and then by machine in 1971 . Obviously, frequent 
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administration of IV doses of opioid by nurses to large numbers of patients is impractical 
and cost prohibitive. Thus, the late 1960s witnessed development of PCA technologies.  
In 1976, the first commercially available PCA pump, the “Cardiff Palliator,” was developed 
at the Welsh National School of Medicine . Since then, PCA devices have evolved 
enormously in technological sophistication, ease of use, flexibility, and portability. 
The smallest concentration at which pain was relieved was termed the “minimum effective 
analgesic concentration” (MEAC). Minimal analgesia is achieved with titration of opioid until 
the MEAC is achieved, which marks the difference between severe pain and analgesia. 
Furthermore, these investigators found a discrete concentration of opioid within an individual 
to consistently provide effective analgesia, whereas the discrete concentration that provided 
analgesia varied considerably among individuals, thus establishing that pharmacodynamic 
variability in response to opioids accounts for individual differences in dose requirements. 
Pharmacokinetic variables (volume of distribution, rates of distribution and elimination) 
consistently failed to correlate with dose requirement; in contrast, an individual’s hourly 
opioid dose and their plasma opioid concentration did correlate. 
Two prerequisites for effective opioid analgesia were thus established:  
1. individualize dosage and titrate to pain relief response to achieve the MEAC and 
establish analgesia,  
2. maintain constant plasma opioid concentrations and avoid peaks and troughs . 
These requirements cannot be achieved with prn or around-the-clock IM injections. 
After titration to achieve the MEAC and establish analgesia, patients use PCA to maintain 
plasma opioid concentrations at or just above their individual MEAC (“optimal plasma 
concentration”). In contrast, patients receiving IM bolus injections experience significant 
periods of severe pain with their plasma opioid concentrations less than their individual 
MEAC, followed by periods of “overshoot” more than the optimal plasma concentration 
resulting in excessive sedation, possible respiratory depression, and no better pain relief. 
2.2 PCA modes and dosing variables 
PCA has several modes of administration. The two most common are demand dosing (a 
fixed-size dose is self-administered intermittently) and continuous infusion plus demand 
dosing (a constant-rate fixed background infusion is supplemented by patient demand 
dosing). Nearly all modern PCA devices offer both modes. 
Less commonly available and less studied modes of administration include infusion 
demand (in which successful demands are administered as an infusion), preprogrammed 
variable-rate infusion plus demand dosing (in which the infusion rate is preprogrammed on 
an internal clock to vary or turn off altogether by time of day), and variable-rate feedback 
infusion plus demand dosing (in which a microprocessor monitors demands and controls 
the infusion rate accordingly).  
For all modes of PCA, there are the following basic variables: initial loading dose, demand 
dose, lockout interval, background infusion rate, and 1-h and 4-h limits. The initial loading 
dose allows for titration of medication when activated by the programmer (not the patient). 
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The initial loading dose can be used by nurses in the postanesthesia care unit (PACU) to 
titrate opioid to the MEAC or by postsurgical nurses to give “breakthrough” doses. 
The demand dose (sometimes called incremental or PCA dose) is the quantity of analgesic 
given to the patient on activation of the demand button. To prevent overdosage by continual 
demand, all PCA devices use a lockout interval (or delay), which is the length of time after a 
successful patient demand during which the device will not administer another demand 
dose (even if the patient pushes the demand button).  
The background or continuous infusion is a constant rate infusion that is administered 
regardless of whether the patient activates demand doses. Some devices allow entry of 1-h 
and/or 4-h limits, with the intent of programming the device to limit the patient over either 
1-h or 4-h intervals to less total cumulative dose than were they to successfully activate the 
demand button at the end of each lockout interval. Use of these 1-h and 4-h limits is 
controversial.  
Proponents argue that these limits provide additional safety, whereas detractors argue that 
no data demonstrate enhanced safety. Moreover, if a patient uses enough demand doses to 
reach the 1-h or 4-h limit, they probably require more analgesic instead of being locked out 
from further access for the balance of the interval.  
The alarm on most devices is nonspecific and nurses typically do not recognize if this 
condition has triggered the alarm. Most modern microprocessor-driven PCA devices allow 
for programming in the “PCA mode” (in which a continuous infusion is not offered) or the 
“PCA + continuous mode.” Whereas earlier PCA devices allowed for entry of parameters in 
units of “mL” or “mg,” many newer devices also allow for entry in “μg” units, thereby 
reducing the potential for programming error when using fentanyl or sufentanil.  
The demand dose and lockout interval (as well as the background infusion—see the hazards 
of continuous background infusions with IV-PCA under the safety section below) deserve 
further discussion. In practice, most patients have an inherent maximum frequency of 
demands. Thus, if the demand dose is too small, they refrain from making demands and 
may become frustrated with PCA, resulting in poor pain relief .  
For PCA to be successful, the demand dose should produce appreciable analgesia with a 
single demand . However, if the demand dose is too large, plasma drug concentration may 
eventually reach toxic levels. There is an optimal range of doses for each opioid, albeit a 
wide enough dose range to accommodate the pharmacodynamic variability in response to 
opioids among individuals. 
It is possible to coach patients to increase the demand rate. If the demand dose is changed 
during PCA treatment, patients will alter their demand rate to accommodate the change, 
thus maintaining a consistent plasma opioid concentration.  
The lockout interval is designed to prevent overdose. Ideally, it should be long enough for 
the patient to experience the maximal effect of one dose before another is permitted, thus 
preventing “stacking” of doses. Therefore, speed of onset of analgesia is paramount in 
setting the lockout interval. Based on this rationale, one might consider using a slightly 
shorter lockout interval when using the “fentanyl family of opioids” compared to morphine 
or hydromorphone.  
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However, once titration to MEAC has been achieved, there appears to be no clinically 
appreciable major differences in time of onset of analgesia among the opioids commonly 
used for PCA . The rate of drug distribution (flux) between plasma and brain is a useful 
concept in determining the lockout interval. While drug flux is positive, there is net 
movement of drug from plasma to brain and drug effect increases. The next dose should be 
administered when net flux becomes negative, i.e., when drug is leaving the brain and effect 
has peaked. 
The change from positive to negative flux occurs over a similar length of time for diverse 
opioids. Many studies examined the relative brain and spinal cord central nervous system 
(CNS) concentration profiles of opioids. CNS concentration was expressed as a percentage 
of its maximum value. Relative onset was defined as the time that the relative CNS 
concentration first reached 80% of maximum and relative duration was defined as the 
period during which the concentration remained more than 80%. For an IV bolus dose of all 
the common opioids, relative onset varies from approximately 1 min for alfentanil to 6 min 
for morphine, and relative durations are 2 min and 96 min, respectively. 
They concluded that, although all of the common opioids (except alfentanil) have kinetic 
and dynamic properties suitable for IV-PCA, the relatively long duration of morphine 
makes it particularly suited for a gradual titration approach.  
Furthermore, titration is improved by frequent administration of small doses after the initial 
“loading” period. Thus, there appears to be pharmacokinetic rationale for the empirically 
derived use of 5–12 min lockout intervals for the opioids commonly used for IV-PCA.  
2.3 Choice of analgesic 
All of the common opioids have been used successfully for IV-PCA, with morphine having 
been studied the most. Whichever opioid is chosen for IV-PCA, knowledge of its 
pharmacology is prerequisite for setting the dosing variables of the PCA device. A review of 
the practical clinical pharmacology of opioids, as it pertains to management of IV-PCA, is 
essential.  
Parenteral opioids have three profiles of μ opiate-receptor binding capacity: pure agonists, 
agonist-antagonists, and partial agonists. Pure agonists are mainstays of acute pain 
management because they provide full μ-receptor binding, i.e., there is no analgesic ceiling 
(e.g., titration of more opioid results in better pain relief).  
There is a “clinical ceiling” in that side effects such as sedation, specifically respiratory 
depression, often prevent further dosing before achieving adequate pain relief. The μ 
agonists are equally effective at equianalgesic doses (e.g., 10 mg of morphine = 2 mg of 
hydromorphone = 100 mg of meperidine). Similarly, there are no differences in side-effect 
profile, although individual patients may experience reproducible nausea and vomiting or 
pruritus with one drug but not another.  
All μ-agonists reduce propulsive gut activity and coordination, contributing to 
postoperative ileus. Contrary to surgical myth, no individual μ-agonist has less effect on gut 
motility: in conventional IV-PCA doses, morphine, meperidine, and fentanyl have similar 
effects on the bile ducts and sphincter of Oddi.  
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There is evidence that agonist-antagonists share this activity to a lesser degree. Metabolites 
and routes of elimination differ markedly between μ-agonists, providing one rationale for 
choosing an opioid for IV-PCA.  
The agonist-antagonist opioids provide κ-receptor activation and μ-receptor antagonism. 
Although they are marketed as having a ceiling effect on respiratory depression, thereby 
providing a greater margin of safety, this effect appears only at very large doses relative to 
μ-agonists. Most importantly, the agonist-antagonists possess an analgesic ceiling, rendering 
them unable to reliably provide a level of pain relief comparable to the μ-agonists. Thus, 
although the successful use of an agonist-antagonist for IV-PCA has been described for 
gynecologic surgery , they are not commonly used in clinical practice and would not reliably 
provide adequate analgesia for moderate-to-severe pain conditions.  
Furthermore, agonist-antagonists can provoke an acute withdrawal response in patients 
who have already received a μ-agonist or are maintained on one chronically. As a result of ς-
receptor activation, they also have a frequent incidence of disturbing psychotomimetic side 
effects.  
Interestingly, there appears to be a major gender difference in response to agonist-
antagonists. Although women consistently experience dose-dependent analgesia, an 
antianalgesic response with increased pain compared with placebo was observed in men 
receiving nalbuphine . Partial agonists produce only a partial response in binding to μ 
receptors, thereby limiting the analgesia that can be achieved. They are not used commonly 
for IV-PCA.  
Morphine remains the “gold standard” for IV-PCA, as the most studied and most 
commonly used IV-PCA drug. It is important to note that morphine has an active 
metabolite—morphine-6-glucuronide (M6G)—that also produces analgesia, sedation, and 
respiratory depression. Whereas morphine is eliminated mainly by glucuronidation, its 
active metabolite relies predominantly on renal excretion for elimination. Prolonged and 
profound delayed onset respiratory depression has been reported in patients with renal 
failure receiving parenteral morphine. 
Hydromorphone is a good alternative for morphine-intolerant patients or those with altered 
renal function because it is metabolized primarily in the liver and excreted primarily as an 
inactive glucuronide metabolite .A demand dose of 0.2 mg of Hydromorphine is considered 
equi-analgesic to 1.0 mg of morphine since it is approximately six times as potent as 
morphine.Following this analgesic advantage over morphine, it is commonly used 
PCApumps at a concentration of 0.5 mg/ml or 1 mg/ml. Hydromorphine is ideally suited 
for opioid-tolerant patients, increasing the interval between refilling the drug reservoir. 
Fentanyl is considered 80–100 times as potent as morphine with single doses or brief periods 
of administration. However, because of its short duration of action, particularly in the early 
phase of administration (owing to redistribution pharmacokinetics), double-blind IV-PCA 
comparator trials have suggested 25–30 μg fentanyl to be equianalgesic to 1 mg morphine as 
an IV-PCA demand dose, i.e., 33–40 times as potent as morphine. Fentanyl has a quicker 
onset than morphine and better suited for iv-PCA probably due its lipophilicity. Fentanyl 
has been used successfully for IV-PCA . It is an excellent alternative for morphine-intolerant 
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patients and is suitable for patients with renal failure because it does not rely on renal 
excretion for elimination.  
Although meperidine has traditionally been the second most common μ-agonist opioid 
prescribed for IV-PCA, its routine use for IV-PCA is strongly discouraged . Meperidine has 
a neurotoxic metabolite, normeperidine, that possesses no analgesic property and relies 
mostly on renal excretion for elimination. Normeperidine accumulation causes CNS 
excitation, resulting in a range of toxic reactions from anxiety and tremors to grand mal 
seizures. Unwitnessed seizures with loss of airway reflexes can result in severe permanent 
anoxic brain injury or death.  
Use of sufentanil, alfentanil, and remifentanil for IV-PCA has been reported, with sufentanil 
studied the most . With sufentanil, an initial demand dose of 4–6 μg appears to be most 
appropriate. In contrast to the longer-acting opioids discussed above, a small background 
infusion may be necessary to sustain analgesia with sufentanil. Owen et al. could not identify 
an optimal dose and administration rate for alfentanil, concluding that it is not a useful drug 
for IV-PCA. Because of its ultra-short duration, remifentanil is probably only appropriate for 
IV-PCA use in short duration, severe episodic pain conditions such as labor pain.  
3. Materials and method 
This prospective, randomized study was approved by the Ethics Committee of the 
Emergency Clinical Hospital Constanta and included 70 patients undergoing major elective 
abdominal surgery. 
The patient inclusion criteria in the study were: over 70 years old; status ASA I –III; 
scheduled major abdominal surgery; normal preoperative mental status, defined by score≥ 8 
in the adapted Abbreviated Mental Test (AMT–Table 1); absence of contraindications for 
epidural anesthesia (clinical or laboratory); absence of extreme malnutrition or of cerebral 
vascular insufficiency. 
 
Age 
Time 
Hospital address 
Year 
Hospital name 
Recognizes two persons (for example, physician, assistant) 
Date of birth 
Year First World War began 
Name of the President of the country 
Counts backwards from 20 to 1 
*The patients were asked to answer these 10 questions.Each correct answer received one point. 
Table 1. Abbreviated Mental Test (AMT)* 
On the day preceding surgery, during the pre-anesthesia interview, the patients signed the 
informed consent and received written and verbal instruction regarding the use of PCA or 
PCEA. 
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The patients were randomly assigned to two groups, using the random numbers list 
method: the PCA group – 35 patients with intravenous postoperative analgesia (morphine), 
the PCEA group – 35 patients with postoperative analgesia by epidural catheter (sufentanyl-
bupivacaine). 
In the PCEA group, before surgery, a thoracic (T7 – T11) epidural catheter was inserted in 
each patient, depending on the location of the surgery. 
All surgeries were performed under balanced general anesthesia (induction with propofol, 
sufentanyl and atracurium, maintenance with sevoflurane, sufentanyl and atracurium) with 
standard intraoperative monitoring. After surgery, the patients were transferred to the 
Postoperative Care Unit. 
In the PCA group, analgesia was initiated with a loading dose of 5 mg morphine 
intravenously, and subsequently the PCA analgesic pump (B.Braun Melsungen) was 
programmed to provide 1.5 mg morphine boluses intravenously with a blocking interval of 
8 minutes. 
For the postoperative analgesia in the PCEA group, we used a combination of bupivacaine 
0.125% and sufentanyl 5 µg/ml administered by the patient-controlled analgesia pump 
(B.Braun Melsungen). The settings of the pump parametrs were: 2-3 ml bolus, safety interval 
of 12 minutes, and a basal infusion rate of 3 – 5 ml/hour. 
In order to quantify the severity of postoperative pain, the patients were asked to use the 10 
cm Visual Analogue Scale (VAS) graded from 0 cm ( no pain) to 10 cm (unbearable pain). 
The VAS score was recorded daily at rest after coughing at 8 am, 12 pm, 8 pm, during the 
first 5 days after surgery. To optimize analgesia and minimize sedation and haemodynamic 
instability, the patient control setting was checked throughout the day for individual 
adjuatments. 
When inadequate analgesia was noted (VAS>3), additiona injectable acetaminophen (1 g 
i.v.) or ketoprofen (100 mg i.v.) was administered. 
Overall, the patient satisfaction score regarding postoperative analgesia was recorded on the 
5th day after surgery (insufficient analgesia = 0, relatively good analgesia =1, good 
analgesia=2, excellent =3). 
The patients’ sedation was evaluated using a 4-point sedation scale (0=awake, opens eyes 
spontaneously, 1 = slightly sleepy, openes eyes on verbal stimuli, 2=moderately sleepy, 
opens eyes on tactile stimuli, nociceptive, 3=exremely sleepy, unresponsive). 
The incidence of adverse effects caused by the opioid was evaluated: pruritus (present or 
absent), nausea or vomiting (present or absent). 
These parametrs were recorded daily at 8 am, 12 pm, 8 pm, during the first 5 days after 
surgery. 
The sensitive block was tested daily using the blunt pin prick technique as well as the 
motor block using the Bromage scale (0= free movement of the lower limb,1= cannot lift 
the extended lower limb; 2= cannot flex the knee, 3= lower limb completely motionless). 
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The blood pressure, heart rate, respiration rate, SpO2, were monitored every two hours 
during the first 5 days after surgery.  
Gastrointestinal function was evaluated by systematically questioning the patients 
regarding the recovery of the digestive tolerance and transit of gases. 
The statistical data proccessing was performed using the Student’s t-tests and chi-square 
test. Values of <0.05 were considered statistically significant. 
4. Results 
A total number of 108 patients were scheduled for major abdominal surgical interventions at 
the Emergency Country Clinical Hospital in Constanta during this study. 
Out of these, 38 (35%) were not included in the study for various reasons: patient (4%), 
severe cardiopulmonary conditions or MT score <8 ( 24%), neurological dysfunction (2%), 
patient death (6%). 
The remaining 70 patients were randomly assigned to two groups: the PCA group, PCEA 
group. 
Six patients did not complete the postoperative study or were excluded from the 
postoperative data analysis due to the absence of surgical resection (2 patients in each 
group) or to their non-compliance to the patient-controlled analgesia devices; these patients 
requested conventional analgesia (2 patients in the PCEA group). 
Demographic and intraoperative data were comparable in both groups, and there were no 
statistically significant differences regarding the duration or type of surgery (Table 2). 
No significant differences were noticed between the two groups regarding the 
intraoperative need for infusion solutions. 
The patients in the PCEA group received less sevoflurane (p=0.0001) and sufentanyl 
intravenously (p=0.0001) during surgery, however they required significantly more 
ephedrine (p=0.0001) than the patients in the PCA group. 
At the end of surgery, the duration of mechanical ventilation was similar in both groups, 
however extubation was performed significantly earlier in the PCEA group than in the PCA 
group. 
The duration of patient-controlled analgesia was similar in both groups (PCA GROUP -70 ± 
22 hours), avalid situation concerning the daily number of analgesic boluses used by the 
patients. The postoperative patient-controlled analgesic consumption is presented in Table 3. 
The VAS score analysis shows that PCEA ensured significantly better (p=0.0001) 
postoperative pain management than PCA at rest (PCEA 22.93 ± 10, PCA 38.74 ± 8) and after 
coughing (PCEA 32.45 ± 13.05, PCA 45.40 ± 11.6) during the first 5 days after surgery . 
During the first day after surgery, a significantly smaller number of patients in the PCEA 
group requested additional analgesia (VAS ≥4) compared with the patients in the PCA 
group (Table 4). 
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Parameter PCA group 
(n=35) 
PCEA group 
(n=35) 
Age (years) 
Weight (kg) 
Gender 
           Surgery 
           Colectomy 
           Gastrectomy 
           Cephalic pancreatectomy 
           Absence of resection 
Mean duration of surgery (minutes) (range) 
Average sevoflurane (%) 
Sufentanyl intravenously (µg/kg) 
Crystalloids (l) 
Colloids (l) 
Incidence of systolic hypotension intraoperatively (<90 
mmHg) 
Duration of systolic hypotension intraoperatively 
(minutes) 
Ephedrine intravenously (mg) 
Postoperative extubation (minutes) 
Duration of postoperative mechanical ventilation 
(minutes) 
76.8 ± 4.7 
69.3 ± 15.5 
17 F/18M 
 
26 (74%) 
2 (6%) 
5 (14%) 
2 (6%) 
242 (172 -295) 
0.8 (0.6 – 1) 
1.7 (1.3-2.2) 
5 (4-6) 
0.5 (0-1) 
21 (60%) 
 
5 (0 -209 
 
0 (0-0) 
60 (32-90) 
27 (10-65) 
 
± 5.6 
66.5 ±14.2 
15 F/20M 
 
20 (57%) 
6 (17%) 
7 (20%) 
2 (6 %) 
230 (180-305) 
0.5 (0.4-0.6)* 
0.3 (0.3-0.4) 
5 (4-6) 
1.0 (0.5-1.5) 
26 (74%) 
 
15 ( (5-30) 
 
12 (6 -36%)* 
30 (17 -57)* 
27 (12-45) 
Data presented as median ± DS, median or numeric 
*p< 0.05 between the two treatment groups 
Table 2. Demographic and perioperative data of study groups 
 
Postoperative day Morphine sulphate i.v. 
(mg/day) 
PCA group 
Bupivacaine epidural 
(mg/day) 
PCEA group 
Epidural sufentanyl 
(µg/day) 
PCEA group 
1 
2 
3 
4 
5 
25 (24 - 44) 
19 (8 -32) 
10 (0 -21) 
0 (0-0) 
0 (0-0) 
169 (150-236) 
158 (120-216) 
127 (94-153) 
50 (0 -120) 
0 (0-0) 
68 (57-94.5) 
63 (48-87) 
51 (37-61) 
20 (0 -48) 
0 (-0) 
Data presented as median;  
PCA group = intravenous patient-controlled analgesia 
PCEA group = epidural patient-controlled analgesia 
Table 3. Postoperative consumption of patient –controlled analgesic 
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Postoperative 
day 
Number of patient who required 
acetaminophen intravenously 
Number of patient who required ketoprofen 
intravenously 
PCAgroup 
no.(%) 
PCEA group no.(%) PCAgroup no.(%) PCEA group no.(%) 
1 
2 
3 
4 
5 
18 (54) 
18 (54) 
19 (58) 
15 (45) 
12 (36) 
11(35) 
15 (48) 
17 (55) 
17 (55) 
10 (32) 
15 (45) 
6 (18) 
3 (9) 
2 (6) 
1 (3) 
5 (16)* 
3 (10) 
3 (10) 
3 (10) 
0 (0) 
Data presented as n.(%) *p<0.05 between the two study groups; The PCA group = intravenous patient-
controlled analgesia; The PCEA group = epidural patient-controlled analgesia 
Table 4. Postoperative consumption of additionally requested analgesic in the two study 
groups 
The patient satisfaction score was significantly higher (p=0.012) in the PCEA group 
compared to the PCA group (Table 5). 
 
Parameter PCA group (n=33) PCEA group (n= 33) 
Recovery of intestinal transit (hours) 
Digestive tolerance (hours) 
Nausea and vomiting 
Systolic arterial hypotension (<90 mmHg) 
SpO2 <95% 
Moderate pulmonary complications 
Major pulmonary complications 
Urinary tract infections 
Pruritus 
Postoperative delirium 
Duration of hospitalization (days) 
Patients satisfaction score  
(no. of patients with score 0/1/2/3) 
AMT score 
(no. of patients with score < 8/9/10) 
115 (90-144) 
182 (140-240) 
10 (30%) 
0 (0%) 
5 (15%) 
2 (6%) 
1 (3%) 
5 (15%) 
1 (3%) 
8 (24%) 
11.5 (8 -16) 
0/3/19/11 
 
5/13/15 
80 (60 -120)* 
142 (120 -164)* 
10 ( 32%) 
5 (16%) 
3 (10%) 
3 (10%) 
1 (3%) 
1 (3%) 
1 (3%) 
8 (26%) 
10.5 (8-15) 
0/1/9/21* 
 
1/7/23 
Data presented as n.(%);  
*p<0.05 between the two study groups;  
The PCA group = intravenous patient-controlled analgesia;  
The PCEA group = epidural patient-controlled analgesia; 
Patient satisfaction score is: insufficient =0, relatively good= 1, good= 2, excellent =3 
Table 5. Postoperative status, adverse events, and patient satisfaction score in the two study 
groups 
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The daily recorder AMT scores had, before surgery, similar values in both groups, while 
after surgery the PCA group had lower values during the 4th and 5th day after surgery. 
There were no significant differences between the two groups regarding the daily values of 
oxygenation during the first 5 days after surgery and the number of minor occurrences of 
asymptomatic hypoxia detected by pulse oximetry. Three patients in the PCA group and 2 
patients in the PCEA group had at least one episode of a fall in the SpO2 to between 90 and 
95%. One patient had a much lower SpO2 value between 85 and 90%. 
Five patients in the PCEA group had postoperative hypotension corrected by volume 
repletion. This event was not noted in the PCA group. 
The frequency of postoperative delirium was similar in the PCA group (8 patients, 24%) and 
the PCEA group (8 patients, 26%). The patients with delirium did not have an analgesic 
consumption or pain score different from those without delirium. 
Postoperatively, the AMT score was lower in the PCA group compared to the PCEA group. 
Recovery of digestive tolerance (p=0.019) and bowel movement (p= 0.005) occured 
significantly sooner in the PCA group compared to the PCEA group. 
The incidence of pruritus, nausea and vomiting was almost equal in the two study 
groups. 
The duration of hospitalization was similar for the patients in the two groups (Table 5). 
5. Discussion 
Effective analgesia reduces perioperative stress and the rate of complications, extremely 
important issues in abdominal surgery. The particularities of the elderly patient require 
ongoing efforts to adapt current analgesic techniques in order to improve the prognosis of 
surgeries in this category of patients. 
The main conclusion of our study is that in elderly patients , patient-controlled analgesia 
techniques, intravenously or epidurally, ensure an efficient management of postoperative 
pain. 
Epidural analgesia provides better control of postoperative pain at rest as well as after 
coughing, without increasing the incidence of complications, a compared to intravenous 
analgesia. Improved mental status of the patients and faster recovery of the digestive 
function were noted in the PCEA group. 
In elderly patients, the difficulties associated with the use of patient-controlled analgesia 
techniques were mainly caused by the inability to lean the correct use of analgesic pumps. 
Previous studies revealed the need for a closer supervision of elderly patients and the 
compulsory frequent adjustment of the administered doses, however, in our study the 
adjustment of the initial settings of patient-controlled analgesia was seldom necessary. In 
the PCA group, the initial setting was not changed because no signs of overdose were 
recorded, and in the PCEA group only 5 patients (16%) required alterations of the bolus 
dosages, to adapt it to the patient requirements. 
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Learning and acquiring the concept of patient control obviously involves an adequate 
preoperative mental status. The preoperative patient selection using the AMT scores 
enabled us to identify those with pre-existing cognitive impairments and consequently these 
patients were not enrolled in the study .This aspect might explain why only 3 % of the 
selected patients refused the patient-controlled devices and requested conventional 
analgesia. The high level of acceptance by the selected patients encourages us to recommend 
the routine pre-operative use of the AMT to ensure effective management of postoperative 
care in elderly patients . 
The analysis of the patient satisfaction scores reveals the superiority of the PCEA 
techniques, explained by the better analgesic efficiency associated to the low incidence of 
adverse events. An important issue to consider is that in the PCEA mode patient control is 
partial, since it is possible to establish a basal analgesic perfusion rate. This aspect is 
extremely important for confused or sleepy patients who cannot control effectively the 
analgesic device. The intravenous continuous analgesic infusion is not recommended since 
it involves a higher risk of respiratory depression even at low doses . 
Abdominal epidural analgesia improves the postoperative recovery of the intestinal transit 
compared to parenteral analgesia. In our study, recovery of bowel movement and digestive 
tolerance in the PCA group were delayed, compared to the PCEA group. Clinical studies in 
which the epidural catheter was located at T12 or lower did not show any benefits regarding 
the recovery of the intestinal function , that is why we took care to always place the cather at 
the thoracic level. 
The incidence of pulmonary complications in this study was similar to that noted in other 
studies with younger patients undergoing the same type of surgeries. The choice of 
analgesic techniques does not seem to have any influence on the incidence of moderate or 
major pulmonary complications. 
The cardiovascular changes were clinically insignificant. As expected, in the PCEA group 
the hemodynamic instability was higher intraoperatively, requiring a higher consumption of 
ephedrine, or postoperatively, when 5 patients experienced episodes of moderate 
hypotension. 
In the patients of the PCEA group, the risk of orthostatic hypotension and motor blockage of 
the lower limbs during postoperative mobilization may neutralize the benefit of faster 
postoperative recovery. In our study, the adjustment of pre-established analgesic doses may 
explain the lack of the significant hemodynamic instability or motor blockage. 
6. Conclusion 
This study shows that patient-controlled analgesic techniques, regardless of the epidural or 
parental route used, are effective in elderly patients.  
An epidural analgesia is better than parenteral analgesia and ensures better pain 
management with improved mental status and faster recovery of intestinal activity, without 
influencing cardiorespiratory morbidity. 
This postoperative analgesia method is a new, promising technique for elderly patients 
undergoing major surgery. 
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